Development and Validation of 2-Azaspiro [4,5] Decan-3-One (Impurity A) in Gabapentin Determination Method Using qNMR Spectroscopy

• Main Authors: Nataliya E. Kuz’mina, Sergey V. Moiseev, Mikhail D. Khorolskiy, Anna I. Lutceva
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Molecules
• Subjects: gabapentin; impurity A; validation; limit of the quantitation; linearity; accuracy
• Online Access: https://www.mdpi.com/1420-3049/26/6/1656

The authors developed a ¹H qNMR test procedure for identification and quantification of impurity A present in gabapentin active pharmaceutical ingredient (API) and gabapentin products. The validation studies helped to determine the limit of quantitation and assess linearity, accuracy, repeatability, intermediate precision, specificity, and robustness of the procedure. Spike-and-recovery assays were used to calculate standard deviations, coefficients of variation, confidence intervals, bias, Fisher’s <i>F</i> test, and Student’s <i>t</i>-test for assay results. The obtained statistical values satisfy the acceptance criteria for the validation parameters. The authors compared the results of impurity A quantification in gabapentin APIs and capsules by using the ¹H qNMR and HPLC test methods.